SV Tech Ventures is a venture capital investment firm established in 2015 and located in Palo Alto, California. The firm concentrates on investing in companies that have effectively showcased their ability to develop advanced technologies. Its investment focus spans across various sectors, including healthcare, software, and hardware, reflecting a commitment to supporting innovative firms that demonstrate significant potential for growth and technological advancement.
Secure and reliable voice AI customer support agents for banking, insurance, fintech, and more. We integrate with existing core systems and leverage the latest in AI research to resolve all customer calls end-to-end.
Martin
Seed Round in 2025
Your personal voice AI.
Truewind
Seed Round in 2023
Truewind is an AI-powered accounting and finance software provider that offers an innovative platform designed to enhance bookkeeping and financial management for startups. The company delivers a comprehensive financial back office experience through its artificial intelligence technology and concierge service. Truewind's platform enables businesses to establish reliable bookkeeping practices and develop detailed financial models, ensuring efficient operations and sound financial planning.
LifeAt
Seed Round in 2023
LifeAt is a company that creates modular productivity software designed to enhance focus and productivity. Its primary offering is a digital workspace that features calming landscape videos, serene scenarios, and soothing music to help users concentrate. The platform allows individuals to study or work in a virtual environment enriched by the presence of popular influencers and celebrities, providing a unique atmosphere for productivity. By integrating these elements, LifeAt aims to simplify productivity management and reduce distractions, allowing users to dedicate more time to their tasks.
Recall.ai
Seed Round in 2022
Recall.ai is a software Development company.
Artly Coffee
Series A in 2022
Artly Coffee, founded in 2020 and based in Seattle, Washington, operates hybrid coffee stores that feature a robot barista. This innovative approach combines artificial intelligence and computer vision to create specialty coffee. The robot barista learns various coffee-making techniques from expert human baristas, ensuring high-quality beverages. Customers can customize and place their orders through an application, which the robots process, thereby reducing the risks associated with human contact and enhancing public health safety. Artly Coffee's unique blend of technology and coffee craftsmanship sets it apart in the specialty coffee market.
Nue
Seed Round in 2022
Nue is a prominent revenue management platform that specializes in automating sales and finance processes for businesses of all sizes. Its comprehensive suite of features includes automated pricing and quoting, sales enablement tools, and financial reporting and analytics. By leveraging usage-based billing and accurate analytics, Nue's platform enhances the efficiency of sales strategies and optimizes pricing models. This enables companies to improve their cash flow and streamline their operations, ultimately accelerating sales and fostering growth.
Sentieon
Series B in 2021
Sentieon, Inc. is a biotechnology company founded in 2014 and headquartered in Mountain View, California, specializing in cloud-based bioinformatics solutions for the life sciences and clinical markets. The company develops a suite of bioinformatics tools designed for the efficient processing of genomics data, focusing on high accuracy and computational efficiency. Key products include Sentieon DNAseq, which facilitates germline DNA analysis, and Sentieon TNseq, used for detecting somatic variants in tumor-normal samples. Sentieon's software solutions are characterized by their scalability, deployability, and upgradability, allowing them to adapt to various user needs. The company's advanced algorithms and robust software implementation ensure rapid turnaround times and consistent results, benefiting scientists, clinicians, and patients by enhancing precision in genomic data analysis.
Emboline
Series D in 2021
Emboline, Inc. is a medical device company specializing in the development of cardiovascular embolic protection devices for various cardiac procedures. The company has created innovative technologies such as the Emboline Complete Accessible Protection and the Emboliner catheter, which are designed to protect the arterial bed and cerebral arteries, respectively. These devices are particularly useful during percutaneous heart valve repair and replacement procedures, as they mitigate the risk of embolic events that can impact critical organs. Founded in 2011 and headquartered in Santa Cruz, California, Emboline serves diverse markets, including cardiac surgery, cardiopulmonary bypass, interventional cardiology, and interventional electrophysiology. As of early 2013, Emboline operates as a subsidiary of CardioLogical Solutions.
Oculii
Series B in 2021
Oculii develops advanced AI software for radar systems, aiming to enhance resolution, range, and accuracy while reducing costs compared to traditional solutions. Its technology is essential for the advancement of autonomous vehicles, which require reliable and high-performance perception capabilities in all weather conditions. By utilizing Virtual Aperture Imaging, Oculii's software allows existing radar hardware to achieve higher angular resolution without the need for increased physical antenna count. This innovation enables the extraction of detailed 4D positioning information from low-cost, off-the-shelf radar components, paving the way for improved radar imaging. Oculii collaborates with leading companies in autonomous vehicles, robotics, and drones, positioning itself as a key player in the development of affordable and effective perception technologies for the future of autonomy.
Zenflow
Series B in 2021
Zenflow, Inc. is a medical device company based in San Francisco, California, that specializes in providing innovative solutions for men suffering from benign prostatic hyperplasia (BPH) symptoms. Founded in 2014 by a team of Stanford University Biodesign Fellows in collaboration with leading urologists, the company aims to address the significant unmet clinical need for effective urinary obstruction treatments. Zenflow's primary product is a spring-like device designed to gently prop open the urethra, restoring its normal function without damaging surrounding tissues. This approach prioritizes patient comfort and minimizes invasiveness, offering a less painful alternative to traditional treatments for urinary obstruction caused by an enlarged prostate.
NeuVector
Series A in 2020
NeuVector Inc. specializes in full lifecycle container security, offering a comprehensive cloud-native Kubernetes security platform. Founded in 2015 and headquartered in San Jose, California, the company provides end-to-end vulnerability management, which helps organizations assess risks from known threats. Its innovative container firewall technology safeguards infrastructure against both known and unknown threats. NeuVector's solutions cater to various industries, including government, financial services, healthcare, and transportation. The platform is designed for security, DevOps, and infrastructure teams, enhancing data protection from the development pipeline through to production. It enforces compliance and offers significant visibility and automated controls, which enable clients to efficiently deploy or scale containers while maintaining robust security.
ANA Therapeutics
Seed Round in 2020
ANA Therapeutics Inc. is a biotechnology company focused on the research and development of niclosamide-based vaccines and therapeutics aimed at treating COVID-19. Founded in 2020 and headquartered in Foster City, California, the company is developing a proprietary formulation of niclosamide, which is designed to help medical practitioners effectively treat patients afflicted with the coronavirus. ANA Therapeutics is actively conducting human clinical trials to evaluate the efficacy of its product, ANA001, which comes in the form of capsules. The company's mission is to address the challenges posed by the coronavirus pandemic and contribute to patient care and recovery.
WiBotic
Series A in 2020
WiBotic Inc. specializes in wireless charging and power optimization solutions primarily for robotic systems, including aerial, mobile, and underwater vehicles. Founded in 2014 and based in Seattle, the company offers a range of products such as wireless charging systems, onboard chargers, transmitters, antenna coils, and integrated options. Additionally, WiBotic provides battery intelligence and fleet management software designed to enhance the operational efficiency of robotic fleets, maximizing battery life and reducing charging and maintenance costs. Its technology enables automatic detection of robots or drones, facilitating seamless charging as they approach the wireless platform. WiBotic's solutions are characterized by their safety, reliability, scalability, and ease of implementation, making them suitable for various industrial applications.
Apexigen
Series C in 2020
Apexigen Inc. is a clinical-stage biopharmaceutical company based in San Carlos, California, dedicated to the discovery and development of antibody therapeutics for cancer treatment. The company focuses on creating innovative immuno-oncology products that leverage the patient's immune system to effectively combat and eliminate cancer. Apexigen's therapeutic pipeline includes several candidates such as APX005M and APX201 for immuno-oncology, alongside APX003 and TRK-950 for oncology, as well as APX001 for inflammation and APX003 for ocular diseases. Additionally, the company has developed the APXiMAB platform, which facilitates the discovery of antibodies targeting novel immune system components. Founded in 2010, Apexigen aims to advance next-generation therapies that address significant unmet needs in cancer treatment.
Zeto
Series A in 2020
Zeto Inc. is a medical technology company based in Santa Clara, California, focused on revolutionizing electroencephalography (EEG) practices in hospitals. Established in 2014, Zeto has developed an innovative dry electrode EEG system that features a wireless, easy-to-wear headset designed to enhance patient experience and streamline the EEG process. This system is the first of its kind to receive FDA clearance, eliminating the need for extensive preparation and specialized technicians. It significantly reduces setup time from over 30 minutes to just five, allowing for quicker and more efficient EEG interpretation. The accompanying digital platform offers instant data upload, live viewing capabilities, and analytical tools, enabling remote analysis by neurologists. Zeto has gained recognition for its advancements in EEG technology, receiving multiple awards, including funding from the Epilepsy Foundation and accolades for innovation in medical technology.
Sensel
Series A in 2020
Sensel, Inc. is a technology company that specializes in developing innovative pressure-sensitive input devices aimed at enhancing user interaction in various fields such as music, art, and gaming. Founded in 2013 and based in Mountain View, California, the company has created the PressureGrid technology, which features a high-resolution sensor array capable of detecting multiple touch points along with their individual pressure and orientation. This technology seeks to improve upon existing touch solutions by addressing issues of inaccuracy, latency, and power consumption, while adding an extra dimension of control through force sensitivity. Sensel's products enable a more expressive and intuitive interaction mode, allowing creators and innovators to explore new possibilities. The company has grown from its initial founders to a team of over forty members and has attracted thousands of customers, including several large-scale enterprise clients.
Apexigen
Series C in 2018
Apexigen Inc. is a clinical-stage biopharmaceutical company based in San Carlos, California, dedicated to the discovery and development of antibody therapeutics for cancer treatment. The company focuses on creating innovative immuno-oncology products that leverage the patient's immune system to effectively combat and eliminate cancer. Apexigen's therapeutic pipeline includes several candidates such as APX005M and APX201 for immuno-oncology, alongside APX003 and TRK-950 for oncology, as well as APX001 for inflammation and APX003 for ocular diseases. Additionally, the company has developed the APXiMAB platform, which facilitates the discovery of antibodies targeting novel immune system components. Founded in 2010, Apexigen aims to advance next-generation therapies that address significant unmet needs in cancer treatment.
Dahezi
Series A in 2018
Dahezi is an e-commerce platform focused on women's wear, providing personalized online styling services aimed at transforming the shopping experience for clients in China. By combining data science with human judgment, Dahezi offers tailored selections of apparel, shoes, and accessories that align with individual styles. The platform emphasizes a customer-centric approach, allowing users to enjoy a unique shopping experience that includes the convenience of free returns.
LOOK
Series A in 2018
LOOK is an online supplier that specializes in fashion and lifestyle content, offering a diverse range of products including clothing and consumer goods. The platform features over 5,000 fashion items sourced globally, enabling Chinese users to access worldwide fashion without constraints related to time or geography. LOOK utilizes a combination of machine learning and human customer service to enhance the shopping experience, providing personalized fashion matching services that cater to individual preferences. This innovative approach allows users to seamlessly browse and purchase items, making it a distinctive player in the e-commerce landscape.
Axiom Exergy
Series A in 2018
Axiom Exergy Inc. is an energy storage company focused on developing innovative refrigeration batteries designed for supermarkets, cold-storage facilities, and food processors. Founded in 2014 and headquartered in Richmond, California, the company provides energy management solutions that include thermal energy storage retrofits and software for monitoring and managing energy use in refrigeration systems. Its products feature an optional integrated backup cooling system, which safeguards food from spoilage during power outages. Axiom Exergy also offers services related to energy management, thermal energy systems engineering, and hardware development, aiming to optimize energy consumption and reduce operational costs for commercial buildings with significant thermal loads.
Emboline
Series B in 2018
Emboline, Inc. is a medical device company specializing in the development of cardiovascular embolic protection devices for various cardiac procedures. The company has created innovative technologies such as the Emboline Complete Accessible Protection and the Emboliner catheter, which are designed to protect the arterial bed and cerebral arteries, respectively. These devices are particularly useful during percutaneous heart valve repair and replacement procedures, as they mitigate the risk of embolic events that can impact critical organs. Founded in 2011 and headquartered in Santa Cruz, California, Emboline serves diverse markets, including cardiac surgery, cardiopulmonary bypass, interventional cardiology, and interventional electrophysiology. As of early 2013, Emboline operates as a subsidiary of CardioLogical Solutions.
TriagingX
Seed Round in 2018
TriagingX, based in Silicon Valley, specializes in threat detection software designed to safeguard endpoint systems and data center servers from zero-day attacks without the need for patches. The company has developed the first generation malware sandbox utilized by numerous Fortune 500 companies for daily malware analysis. Currently, TriagingX is advancing to the next generation of sandbox technology, along with a larger scale advanced analytic system hosted on both public and private clouds. This system integrates outputs from malware sandbox behavior, endpoint snapshots, network logs, and other security products to deliver comprehensive analysis of sophisticated attacks. TriagingX's mission is to collaborate closely with clients to proactively identify and address vulnerabilities in their networks, ensuring they remain one step ahead of potential threats.
Carbon Lighthouse
Venture Round in 2018
Carbon Lighthouse, LLC is a technology company specializing in energy solutions for commercial real estate and various other sectors, including education and hospitality. Founded in 2010 and based in San Francisco, Carbon Lighthouse focuses on decarbonizing buildings through its Efficiency Production platform and CLUES® AI software. The company provides energy efficiency measures that help reduce utility bills and carbon emissions, such as optimizing heating, ventilation, and air conditioning systems and installing cost-effective energy-saving equipment. Additionally, Carbon Lighthouse offers onsite energy generation solutions, including solar photovoltaic systems, and consulting services for energy sourcing and regulatory assessments. Its clientele includes building owners and property managers of small to medium-sized buildings, such as community centers and schools. With a track record of delivering significant client value and reducing substantial carbon emissions, Carbon Lighthouse aims to assist clients in achieving their decarbonization goals while enhancing financial performance.
Zenflow
Series A in 2018
Zenflow, Inc. is a medical device company based in San Francisco, California, that specializes in providing innovative solutions for men suffering from benign prostatic hyperplasia (BPH) symptoms. Founded in 2014 by a team of Stanford University Biodesign Fellows in collaboration with leading urologists, the company aims to address the significant unmet clinical need for effective urinary obstruction treatments. Zenflow's primary product is a spring-like device designed to gently prop open the urethra, restoring its normal function without damaging surrounding tissues. This approach prioritizes patient comfort and minimizes invasiveness, offering a less painful alternative to traditional treatments for urinary obstruction caused by an enlarged prostate.
UroDev Medical
Seed Round in 2017
UroDev Medical is focused on designing innovative medical devices to enhance the quality of life for individuals with spinal cord injuries and diseases. The company's flagship product, The Connected Catheter, introduces a semi-permanent, minimally-invasive smart catheter system that measures bladder pressure and wirelessly transmits data to a smartphone. This technology aims to simplify bladder management for millions of users by eliminating the need for intermittent catheters and drainage bags. The system allows both users and clinicians to control a valve that facilitates the emptying of urine from the bladder into the catheter, thereby improving overall bladder care and user experience.
Play Piper
Series A in 2017
Piper is a Minecraft toolbox for budding engineers that leverages kids' love of Minecraft to show them that building real gadgets is effortless and fun. At a time when technology pervades every part of our life, kids learn to passively USE technology, but not to CREATE with it. We believe that giving kids an opportunity to become creators rather than consumers, and to do it through a game their already understand and love is a powerful way to replace screen-time with build-time. Letting kids invent, tinker, and build in the physical world while they are young is the most powerful way to empower them to create the future.
CloudMedx
Venture Round in 2017
CloudMedx Inc. is a software development company that specializes in artificial intelligence solutions aimed at extracting critical clinical insights from electronic health records. Founded in 2014 and based in Palo Alto, California, the company transforms raw healthcare data into actionable insights that enhance clinical operations, documentation, and patient care. Its platform leverages population health history to improve clinical, treatment, and diagnostic outcomes, while also notifying physicians when care is necessary. CloudMedx provides patient-centric tools that facilitate engagement, risk stratification, and actionable insights, serving a range of healthcare entities including managed care organizations, accountable care organizations, physician-led organizations, emergency rooms, urgent care facilities, and lab testing sites. The company’s mission is to unify healthcare systems, enabling better collaboration among providers, payers, and patients, ultimately improving the accuracy and quality of care delivered.
100Plus
Seed Round in 2017
100Plus is a rapidly growing remote patient monitoring platform designed to enhance the care of elderly patients with chronic conditions. The platform provides comprehensive services, including patient outreach, device setup, patient engagement, and automatic billing, all integrated with medical devices. By enabling doctors to monitor high-risk seniors remotely, 100Plus helps to prevent costly episodic care and promotes a higher quality of life for patients. When a Medicare patient receives a 100Plus medical device, it is delivered at no cost to them or their healthcare providers, fully configured and ready for immediate use, eliminating the need for smartphones, apps, Bluetooth, or WiFi.
Magnetic Insight
Convertible Note in 2017
Magnetic Insight, Inc. specializes in magnetic particle imaging (MPI), an innovative imaging technology that utilizes iron oxide nanoparticle tracers and time-varying magnetic fields. The company has developed several products, including the MOMENTUM imager, a pre-clinical MPI solution that produces high-quality images through advanced magnet geometry and a proprietary reconstruction process. Additionally, Magnetic Insight offers VivoTrax, a nanoparticle designed for cell tracking and as a blood pool agent in pre-clinical studies, and Hyper, an add-on module for the MOMENTUM system that assists in identifying treatment targets and administering localized magnetic hyperthermia. Another product, Relax, serves as a particle relaxometry module. Founded in 2012 and headquartered in Alameda, California, Magnetic Insight aims to enhance preclinical diagnostic research by enabling quantitative cell tracking, imaging of vascular functions, and visualization of various biological processes, thereby addressing challenges in clinical and translational research.
Turning Point Therapeutics
Series C in 2017
Turning Point Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative small molecule targeted therapies for oncology. The company designs a range of tyrosine kinase inhibitors (TKIs) aimed at addressing genetic drivers of cancer in both TKI-naïve and TKI-pretreated patients. Its lead drug candidate, repotrectinib, is currently under evaluation in the ongoing Phase I/II TRIDENT-1 trial, targeting patients with ROS1+ advanced non-small-cell lung cancer and those with ROS1+, NTRK+, or ALK+ advanced solid tumors. Additionally, Turning Point's pipeline includes other multi-targeted drug candidates, such as TPX-0046, a RET/SRC inhibitor; TPX-0022, a MET/CSF1R/SRC inhibitor; and TPX-0131, which is an ALK inhibitor in preclinical development. Founded in 2013 and headquartered in San Diego, California, the company aims to advance precision medicine in oncology by addressing unmet medical needs.
Falcon Computing
Series B in 2017
Falcon Computing, founded in 2014 by Dr. Jason Cong, specializes in providing technology solutions for data scientists and software developers in sectors such as Genomics, Machine Learning, Finance, and Computer Vision. The company focuses on simplifying the adoption of heterogeneous accelerated computing through automated compilation tools and runtime management solutions. Its innovative platform allows users to convert C/C++ code into optimized FPGA implementations, enhancing performance, energy efficiency, and productivity. Headquartered in Santa Clara, California, with additional offices in Los Angeles and Beijing, Falcon Computing aims to support companies in integrating advanced acceleration technologies into their data center infrastructures, ultimately making cloud computing more energy-efficient.
Arraiy
Seed Round in 2017
Arraiy, Inc. is a company based in Palo Alto, California, focused on developing an AI-driven production platform for the motion picture and television industry. Founded in 2016 and formerly known as opencv.ai, Arraiy utilizes computer vision and machine learning to enhance the filmmaking process. The company collaborates with major studios, industry veterans, and award-winning artists to innovate visual storytelling and integrate real and virtual worlds seamlessly. Through its platform, Arraiy aims to empower creators with greater creative freedom and redefine the standards of visual content production. As of July 2020, Arraiy operates as a subsidiary of Matterport, Inc.
Cequence Security
Seed Round in 2016
Cequence Security, Inc. is a cybersecurity company based in Sunnyvale, California, specializing in automated application security solutions for organizations that rely on web, mobile, and API services. Founded in 2013, the company offers the Cequence Application Security Platform, which is designed to meet the security needs of modern, internet-driven businesses. This platform provides essential intelligence, insight, and integration, supporting multiple security modules while allowing data sharing with existing security tools. Among its key offerings is the Unified API Protection (UAP) Platform, which combines API discovery, compliance, and real-time detection to safeguard applications against attacks, business logic abuse, and fraud. Cequence Security serves a diverse clientele, including Fortune and Global 500 companies across various industries, and is led by an experienced executive team with backgrounds in prominent cybersecurity firms.
Otter.ai
Seed Round in 2016
Otter.ai, Inc. is a technology company that specializes in artificial intelligence applications for managing voice conversations. Founded in 2016 and headquartered in Los Altos, California, the company offers a mobile and web app called Otter, which allows users to store, search, and share notes from meetings, interviews, and lectures. The platform utilizes advanced speech recognition technology to create real-time transcripts, making the information easily accessible and actionable. Otter's features include speaker separation, speaker identification, and keyword extraction, catering to business professionals, journalists, and students alike. By facilitating collaboration and enabling users to edit, organize, and export their voice notes, Otter.ai enhances productivity and communication in various settings, including education and team environments.
Magia.ai
Venture Round in 2016
Magia.ai, Inc. is a Silicon Valley-based startup that specializes in innovative AI solutions for the retail sector. The company has developed a concept known as Invisible Selling, which focuses on enhancing digital selling through human-like interactions. By leveraging deep domain expertise and insights into selling psychology, Magia.ai aims to foster engagement, trust, and persuasion among shoppers, ultimately facilitating confident and effortless buying decisions.
Deako
Venture Round in 2016
Deako, Inc. is a Seattle-based manufacturer of electrical switches, established in 2015. The company specializes in modular light switches, including dimmers, rockers, scene controllers, and motion sensors. Deako offers an innovative lighting system that allows homeowners to control their lighting easily, either through a smartphone application or smart speakers, with the option to operate the switches manually as well. The design of Deako's switches is customizable to fit individual home aesthetics, enhancing convenience for users who wish to manage their lighting remotely. Deako markets its products online, making their smart lighting solutions accessible to a wide audience.
Brilliant
Seed Round in 2016
We make the Brilliant Control, a smart home control system that replaces an existing light switch.
EpiBiome
Series A in 2016
EpiBiome, Inc. is a precision microbiome engineering company focused on developing therapies to combat infectious diseases in humans and agriculture without relying on small-molecule antibiotics. Founded in 2013 and based in South San Francisco, California, EpiBiome offers innovative phage therapy solutions that target specific strains within the microbiome, addressing issues such as antibiotic resistance and providing alternatives to traditional antibiotics. The company’s therapies are designed to treat conditions like mastitis in dairy cows and infections caused by Escherichia coli in humans. EpiBiome employs advanced sequencing and bioinformatic processes to identify pathogenic bacteria and microbiome alterations that may lead to disease, facilitating patient recovery and enhancing health outcomes. As of mid-2018, EpiBiome operates as a subsidiary of Locus Biosciences, Inc.
TuringSense
Seed Round in 2015
TuringSense, Inc. specializes in wearable sports technology, focusing on enhancing athletic training through its innovative product, PIVOT. This device utilizes a multi-sensor, full-body motion-capture system that operates without cameras, allowing tennis players to receive immediate biomechanical feedback to refine their techniques and reduce the risk of injury. TuringSense's technology is highly versatile, with applications extending beyond sports to include physical therapy, rehabilitation, posture correction, and virtual reality. The system enables users to store and share training data in real-time with coaches, trainers, and even friends and family through social media. Founded in 2014 and based in Campbell, California, TuringSense aims to expand its offerings to encompass additional sports such as golf and swimming in the future.
ScaleFlux
Venture Round in 2015
ScaleFlux, Inc. is a semiconductor company based in San Jose, California, with additional offices in Beijing, Shanghai, and Hangzhou, China. Founded in 2014, ScaleFlux specializes in computational storage solutions that enhance the efficiency of data centers and cloud infrastructure. The company focuses on helping clients manage data growth effectively, particularly in areas such as cloud computing, artificial intelligence, and enterprise applications. By integrating advanced compute engines with solid-state storage, ScaleFlux enables users to improve performance, efficiency, security, and scalability for data-intensive tasks. In addition to its storage and memory products, ScaleFlux offers fully validated firmware, software, and module designs to facilitate product adoption, ensuring customers can leverage optimized storage intelligence to enhance their infrastructure for computing and storage needs.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.